Efficacy and safety of PCSK-9 inhibitors in patients with acute coronary syndrome: a systematic review and network meta-analysis.

BMC Cardiovasc Disord · 2025 · PMC12374482 · PMID 40849610

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

moderately significantno p-value reported

Meta-regression analysis Timing of intervention (≤ 7 days) and baseline LDL-C showed significant/moderately significant associations with improved outcomes.

also in 2,178 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.